The Latest Trading Price of Novartis India Ltd is ₹ 1038 as of 05 May 15:30
. The P/E Ratio of Novartis India Ltd changed from 65.2 on March 2021 to 19.2 on March 2025 . This represents a CAGR of -21.69% over 5 yearsThe P/E Ratio of Panjon Ltd changed from 22.4 on March 2023 to 97.8 on March 2025 . This represents a CAGR of 63.44% over 3 years The Market Cap of Novartis India Ltd changed from ₹ 1362 crore on March 2021 to ₹ 1938 crore on March 2025 . This represents a CAGR of 7.30% over 5 yearsThe Market Cap of Panjon Ltd changed from ₹ 27.28 crore on March 2022 to ₹ 38.6 crore on March 2025 . This represents a CAGR of 9.07% over 4 years The revenue of Novartis India Ltd for the Dec '25 is ₹ 94.65 crore as compare to the Sep '25 revenue of ₹ 99.73 crore. This represent the decline of -5.09% The revenue of Panjon Ltd for the Dec '25 is ₹ 14.18 crore as compare to the Sep '25 revenue of ₹ 14.99 crore. This represent the decline of -5.4% The ebitda of Novartis India Ltd for the Dec '25 is ₹ 31.11 crore as compare to the Sep '25 ebitda of ₹ 33.28 crore. This represent the decline of -6.52% The ebitda of Panjon Ltd for the Dec '25 is ₹ 0.33 crore as compare to the Sep '25 ebitda of ₹ 0.31 crore. This represent the growth of 6.45% The net profit of Novartis India Ltd changed from ₹ 25.74 crore to ₹ 16.09 crore over 7 quarters. This represents a CAGR of -23.55%
The net profit of Panjon Ltd changed from ₹ 0.03 crore to ₹ 0.22 crore over 7 quarters. This represents a CAGR of 212.22%
The Dividend Payout of Novartis India Ltd changed from 118.09 % on March 2021 to 61.15 % on March 2025 . This represents a CAGR of -12.33% over 5 yearsThe Dividend Payout of Panjon Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .
About Novartis India Ltd
Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947.
The Company is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates into four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health.
The origin of Novartis is linked to the origin of three distinct companies namely Geigy, Ciba, and Sandoz.
The history of Geigy goes back to the middle of the 18th century, Ciba was founded around 1860, and Sandoz was set-up in 1886.
In 1970 Ciba and Geigy merged to form Ciba-Geigy Ltd. Sandoz and Ciba-Geigy Ltd continued as separate entities for the next 25 years.
In 1996, in one of the largest corporate mergers in history Sandoz and Ciba-Geigy Ltd.
About Panjon Ltd
Incorporated in Dec.'83 Panjon Limited became public in 1992.
The Company was promoted by Nagin Kothari and Manoj Kothari.
The Company is a leading FMCG company.
It has marked its presence with significant achievements and today commands a remarkable market status.
Panjon today has renowned products like PANJON Tablet , PANJON Balm , PANJON Inhaler, PANJON cough drops, Swad Digestive Drops, Swad Chatpati Drops, Swad Chyawanpra Candy,Percy Masala Candy, Panjon Swad PACHAK range : Shahi Anardana, Special Jeera Goli, Hing Peda, Albela Aam, Khatta Meetha Khajoor, Chatpata Amla, Chulbuli Imli and many more.
The Company manufactures and markets consumer and pharmaceutical products which are low priced and within the reach of the common man.
FAQs for the comparison of Novartis India Ltd and Panjon Ltd
Which company has a larger market capitalization, Novartis India Ltd or Panjon Ltd?
Market cap of Novartis India Ltd is 2,563 Cr while Market cap of Panjon Ltd is 40 Cr
What are the key factors driving the stock performance of Novartis India Ltd and Panjon Ltd?
The stock performance of Novartis India Ltd and Panjon Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Novartis India Ltd and Panjon Ltd?
As of May 5, 2026, the Novartis India Ltd stock price is INR ₹1038.1. On the other hand, Panjon Ltd stock price is INR ₹23.78.
How do dividend payouts of Novartis India Ltd and Panjon Ltd compare?
To compare the dividend payouts of Novartis India Ltd and Panjon Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.